Clinical Trials for Cancer Type: Cervix Uteri

10 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
ECOG-EAY131 (CIRB) Molecular Analysis for Therapy Choice (MATCH) Open
GOG-0237 Comparative Analysis Of CA-IX, p16, Proliferative Markers And Human Papilloma Virus (HPV) In The Diagnosis Of Significant Cervical Lesions In Patients With A Cytologic Diagnosis Of Atypical Glandular Cells (AGC) Open
GOG-0263 (CIRB) Randomized Phase III Clinical Trial Of Adjuvant Radiation Versus Chemoradiation In Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy And Pelvic Lymphadenectomy Open
GOG-0278 Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-Radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy With Pelvic Lymphadenectomy) for Stage IA1 (LVSI+) and IA2-IB1 (=/<2CM) Cervical Cancer Open
GOG-0724 (CIRB) Phase III Randomized Study Of Concurrent Chemotherapy And Pelvic Radiation Therapy With Or Without Adjuvant Chemotherapy In High-Risk Patients With Early-Stage Cervical Carcinoma Following Radical Hysterectomy Open
GOG-3009 Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV Open
UCI-15-78 An Open-Label, Phase I/II, Dose-Escalation Study Evaluating The Safety And Tolerability of GDC-0032 In Patients With Locally Advanced Or Metastatic Solid Tumors Or Non-Hodgkin's Lymphoma And In Combination With Endocrine Therapy In Patients With Locally Advanced Or Metastatic Hormone Receptor-Positive Breast Cancer Open
UCI-16-02 Breast and Cervical Cancer Survivorship in Zambia: Quality of Life, Social Support, and the Role of HIV/AIDS Open
UCI-16-71 A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors Open
UCI-16-96 A Phase 1 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients with Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors Open